Nanoparticle-based drug may soon be launched in healthcare industry
Date: 2018-03-06   Author: Pankaj Singh  Category: #industry

Nanoparticle-based drug may soon be launched in healthcare industry

Acclaimed scientists from the Russian ITMO University may soon revolutionize healthcare and medical devices industry with their latest discovery. As per reliable sources, they have discovered that magnetically-driven nanoparticles containing thrombin are rather effective to stop internal bleeding. A drug based on these nanoparticles, if and when conceived, can apparently be directly delivered to the vascular injury site.

Apparently, these nanoparticles are not hazardous for human beings and can be used for safe diagnosis. They improve clot formation and curb overall blood loss by fifteen times, proving to be rather beneficial for internal bleeding.

Though there are various drugs available for internal bleeding in healthcare and medical devices industry, none of them have proven effective without surgical intervention. The only possible solution, claim scientists, is to develop a rather quick and effective treatment. In this regard, scientists had commenced the development of drugs that may be provided through a simple injection. A constraint with this medication therapy is that the clot formation has to be initiated only at vessel damage without affecting the entire vascular system. ITMO’s latest research, claim reports, seems to be in alignment with this school of thought regarding internal bleeding.

As per research, thrombin enzyme and mineral are the two vital components in magnetically-driven nanoparticles. Thrombin enzyme interacts with fibrinogen protein and leads to clot formation, blocking the damaged vessel. The other important ingredient, the mineral, allows particles to move inside the body with the help of an external magnetic field.

ITMO’s laboratory head, Vladimir Vinogrado, has been quoted stating that synthesizing these nanoparticles had not been easy. It had been vital to keep their size below 200 nanometers without which they would have been deemed unsuitable for an injection. He further added that even the toxicity of the particles with human cells had been tested, post which it was found that these particles are completely safe even with long-lasting exposure.

In the event that this drug is commercially available, it is certain to transform healthcare and medical devices industry outlook, say experts.



About Author


Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj


Post Recommendents

Innovations in surveillance system—a growth enabler in air traffic management
Author: Saipriya Iyer

Transforming air traffic management into a more interoperable, automated, modular and scalable system will potentially reap rewards from developments in virtualization and digital technologies. Seamless high-performing...


Stents industry to witness robust technological innovations with ongoing R&D activities
Author: Pankaj Singh

One of the fastest emerging verticals within the healthcare and medical devices space, the global stents market is set to witness numerous interesting trends in the coming years. Ongoing research and development in the...


Comprehensive Analysis on Bath Fittings and Accesssories Market based on types and application
Author: Ashwin Naphade

The latest Bath Fittings and Accesssories market research added by Market Study Report, LLC, delivers a concise outline regarding the potential factors likely to drive the revenue growth of this industry. The report delivers valuable insights on m...